Latest News

Print

iPods Reach Through Fog of Alzheimer’s with Music.

Dr. Joshua Grill, Director of the Katherine and Benjamin Kagan Alzheimer's Disease Treatment Development Program and leader of the Mary S. Easton Center's Recruitment and Education Program, was featured in the August 12 UCLA Health regarding a campaign to collect pre-owned iPods and MP3 players for Alzheimer's disease and dementia patients in nursing homes.

Print

Alzheimer’s Weekly digs deep to cure the brain disorder.

Dr. Arthur Toga, Professor of Neurology and Director of the Laboratory of Neuro Imaging (LONI) in the UCLA Department of Neurology, was cited in a July 14 Alzheimer's Weekly article that highlighted the Alzheimer's Disease Neuroimaging Initiative, which is performing whole-genome sequencing of more than 800 Alzheimer's patients with the help of the LONI lab.

Print

Why Alzheimer’s drugs rarely help?

Research led by Dr. Zhefeng Guo, Assistant Professor of Neurology, suggesting that the target of current Alzheimer’s drugs is molecularly different than the suspected culprit behind the disease was covered July 3 by Poland's Money and Odkrywcy; July 2 by Psych Central; and July 1 by Bioscience Technology, Investor's Business Daily, HealthCanal, Science Codex and Medical Express. The study was published in the June 28 edition of the Journal of Biological Chemistry.

Print

Music therapy for Alzheimer's patients.

Dr. Joshua Grill, Director of the Katherine and Benjamin Kagan Alzheimer's Disease Treatment Development Program and leader of the Mary S. Easton Center's Recruitment and Education Program was interviewed by CBSLA and KCAL9, June 26, 2013 about music therapy for Alzheimer's disease. Dr. Grill recently initiated the Tunes for Alzheimer's Patients program at the Easton Center. This program provides donated iPods, MP3 players, iTunes gift cards, and other equipment to certified nursing homes and other facilities in the greater Los Angeles area that provide care to Alzheimer's patients. Donors to the program are eligible for a tax deduction for their charitable gift. For more information, visit Tunes for Alzheimer's Patients.

Print

National Institutes of Health: Estrogen therapy has no long-term effect on cognition in younger (age 50-55) postmenopausal women.

A NIH-funded study was released on June 24, reported no long-term benefit or risk on cognition in young postmenopausal women taking conjugated equine estrogens.